IDBS has unveiled what it describes as significant new capabilities to E-WorkBook, its enterprise data management platform, with major enhancements to the web client and integrations with IDBS workflow and analytics engine
IDBS has added a new functionality to its ChemBook electronic laboratory notebook (ELN)
IDBS has launched Omics Workbench, a new web-based product that supports Next Generation Sequencing (NGS) and other omics techniques in research and clinical labs
IDBS has launched the IDBS Biomarker Discovery and Validation Solution, which streamlines biomarker research and improves collaboration, intellectual property management, and scientific understanding of complex disease, leading to new therapies
IDBS has released E-WorkBook Suite 8.2, the latest version of its ELN that captures and stores both contextual and experimental fact data in a searchable, secure, traceable and compliant environment
IDBS has released InforSense Suite 5.1, the latest version of its scientific business intelligence solution, incorporating data integration, analysis and visualisation
From pharmaceuticals to energy, healthcare to consumer goods, IDBS helps research and development (R&D) teams make discoveries that have the potential to transform the lives of populations worldwide.
We are passionate about optimizing scientific process and making data genuinely useful and actionable. As a leading global provider of advanced software for R&D, we provide organizations with the technology they need to securely capture, manage, share and exploit structured and unstructured data.
IDBS has released E-WorkBook Suite 7.1. It is a compliant, secure and extensible electronic laboratory notebook (ELN) designed for research scientists of any discipline.
IDBS has released the latest version of its E-WorkBook Suite - the compliant, secure and extensible Electronic Lab Notebook (ELN) designed for research scientists of any discipline.
IDBS has launched ActivityBase Xtended Edition (ActivityBase XE) v7.0, with improved drug screening capabilites. The new release includes support for complex assay types (e.g. multiplexing and HCS).
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
